Managed care formulary disclosure urged by National Health Council as "patient right".
Executive Summary
MANAGED CARE FORMULARY DISCLOSURE IS "PATIENT RIGHT," NATIONAL HEALTH COUNCIL says in a consumer information guide entitled "Putting Patients First: Patients' Rights and Responsibilities," unveiled at a Nov. 7 press briefing in Washington, D.C. "All patients have the right to concise and easily understood information about their coverage," the consumer brochure declares. Such information includes "the range of covered benefits, required authorizations, and service restrictions or limitations (such as on the use of certain health care providers, prescription drugs and `experimental' treatments)."
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth